Vilon 20mg

Vilon is a dipeptide (Lys-Glu / KE) — just two amino acids — making it one of the smallest bioregulatory peptides in the Khavinson series. The question that immediately follows: can two amino acids do anything meaningful biologically? The Khavinson group's answer, backed by published research, is yes — the KE dipeptide shows thymic tissue-specific activity in preclinical models despite its minimal size. The thymus is the primary target: the organ responsible for T-cell maturation that involutes progressively with age, contributing to the immunosenescence that characterizes aging immune systems.

Thymic involution is one of the most well-characterized features of immune aging. Starting in adolescence, fatty tissue progressively replaces functional thymic parenchyma. Naive T-cell output declines. The peripheral T-cell repertoire narrows. By late adulthood, the thymus is largely non-functional as a primary lymphoid organ. Whether that process can be slowed or studied at the gene expression level using bioregulatory peptides is an active research area. Vilon research examines thymocyte differentiation gene expression, T-cell output markers, and CD4/CD8 ratios in aging models. Several decades of published Khavinson Institute data cover thymic bioregulator research specifically.

Specifications

Storage: Lyophilized: −20°C, away from light. Once reconstituted: 2–8°C, use within 4 weeks.

Quality: HPLC purity analysis, mass spec identity confirmation, endotoxin testing on every batch. COA ships with every order. EU-based QC under CERTALAB S.R.L.

For research purposes only. Not for human consumption.